AVI Polymers Q1 FY27 results showed consolidated revenue at Rs 66 crore and PAT at Rs 4 crore with gross profit Rs 5 crore, marking the company’s transition to meaningful commercial polymer manufacturing operations.

Brady and Morri Q1 FY27 results showed standalone revenue declining 12% to Rs 17 crore and PAT nearly halving to Rs 77 lakh from Rs 1 crore in Q1 FY26 as gross profit contracted.

Achyut Health Q1 FY27 results showed standalone revenue flat at Rs 3 crore while PAT grew 28% to Rs 14 lakh as gross profit more than doubled to Rs 0.15 crore from Rs 0.07 crore in Q1 FY26.

Citizen Solar Q1 FY27 results showed standalone revenue surging to Rs 76 crore from near-zero in Q1 FY26 with PAT at Rs 5 crore, marking the company’s transition to commercial-scale solar energy operations.

M K Proteins Q1 FY27 results showed standalone revenue flat at Rs 115 crore while PAT halved to Rs 1 crore from Rs 3 crore as gross profit fell 56% to Rs 2 crore on soyabean crush margin compression.

Birla Precision Q1 FY27 results showed PAT surging 87% to Rs 5 crore despite gross profit falling 73% to Rs 1 crore, pointing to significant non-operating income supporting the net profit alongside core manufacturing margin pressure.

Jay Ushin Q1 FY27 results show standalone revenue jumping 29% to Rs 276 crore while PAT held at Rs 4 crore, with gross profit dipping slightly as input costs rose alongside the strong revenue growth.

EASTINDIA Q1 FY27 results showed standalone revenue declining 4% to Rs 63 crore while PAT held stable at Rs 1 crore with 6.7% growth, reflecting effective cost management despite the revenue softness.

Jeevan Scientific Q1 FY27 results showed consolidated revenue doubling to Rs 18 crore and PAT swinging to Rs 88 lakh from a loss of Rs 3 crore in Q1 FY26 as gross profit also turned positive.

Tilak Ventures Q1 FY27 results showed standalone revenue falling 20% to Rs 6 crore while PAT nearly doubled to Rs 4 crore from Rs 2 crore in Q1 FY26 as gross profit improved 73%.